» Articles » PMID: 20881321

Corticotropin-releasing Factor Signaling and Visceral Response to Stress

Overview
Specialty Biology
Date 2010 Oct 1
PMID 20881321
Citations 70
Authors
Affiliations
Soon will be listed here.
Abstract

Stress may cause behavioral and/or psychiatric manifestations such as anxiety and depression and also impact on the function of different visceral organs, namely the gastrointestinal and cardiovascular systems. During the past years substantial progress has been made in the understanding of the underlying mechanisms recruited by stressors. Activation of the corticotropin-releasing factor (CRF) signaling system is recognized to be involved in a large number of stress-related behavioral and somatic disorders. This review will outline the present knowledge on the distribution of the CRF system (ligands and receptors) expressed in the brain and peripheral viscera and its relevance in stress-induced alterations of gastrointestinal and cardiovascular functions and the therapeutic potential of CRF(1) receptor antagonists.

Citing Articles

The Interaction between Stress and Inflammatory Bowel Disease in Pediatric and Adult Patients.

Belei O, Basaca D, Olariu L, Pantea M, Bozgan D, Nanu A J Clin Med. 2024; 13(5).

PMID: 38592680 PMC: 10932475. DOI: 10.3390/jcm13051361.


The interplay between microbiota and brain-gut axis in epilepsy treatment.

Zhu H, Wang W, Li Y Front Pharmacol. 2024; 15:1276551.

PMID: 38344171 PMC: 10853364. DOI: 10.3389/fphar.2024.1276551.


Role of corticotropin-releasing factor neurotransmission in the lateral hypothalamus on baroreflex impairment evoked by chronic variable stress in rats.

Barretto-de-Souza L, Benini R, Reis-Silva L, Busnardo C, Crestani C Pflugers Arch. 2024; 476(3):351-364.

PMID: 38228895 DOI: 10.1007/s00424-024-02904-5.


Perinatal high-fat diet exposure alters oxytocin and corticotropin releasing factor inputs onto vagal neurocircuits controlling gastric motility.

Carson K, Alvarez J, Mackley J, Travagli R, Browning K J Physiol. 2023; 601(14):2853-2875.

PMID: 37154244 PMC: 10524104. DOI: 10.1113/JP284726.


Modulation of Intestinal Corticotropin-Releasing Hormone Signaling by the Herbal Preparation STW 5-II: Possible Mechanisms for Irritable Bowel Syndrome Management.

Elbadawi M, Ammar R, Rabini S, Klauck S, Efferth T Pharmaceuticals (Basel). 2022; 15(9).

PMID: 36145342 PMC: 9504045. DOI: 10.3390/ph15091121.


References
1.
Sweetser S, Camilleri M, Nord S, Burton D, Castenada L, Croop R . Do corticotropin releasing factor-1 receptors influence colonic transit and bowel function in women with irritable bowel syndrome?. Am J Physiol Gastrointest Liver Physiol. 2009; 296(6):G1299-306. PMC: 2697942. DOI: 10.1152/ajpgi.00011.2009. View

2.
SAFFRAN M, Schally A, Benfey B . Stimulation of the release of corticotropin from the adenohypophysis by a neurohypophysial factor. Endocrinology. 1955; 57(4):439-44. DOI: 10.1210/endo-57-4-439. View

3.
Koob G, Bloom F . Corticotropin-releasing factor and behavior. Fed Proc. 1985; 44(1 Pt 2):259-63. View

4.
Habib K, Weld K, Rice K, Pushkas J, Champoux M, Listwak S . Oral administration of a corticotropin-releasing hormone receptor antagonist significantly attenuates behavioral, neuroendocrine, and autonomic responses to stress in primates. Proc Natl Acad Sci U S A. 2000; 97(11):6079-84. PMC: 18561. DOI: 10.1073/pnas.97.11.6079. View

5.
Halpert A, Drossman D . Biopsychosocial issues in irritable bowel syndrome. J Clin Gastroenterol. 2005; 39(8):665-9. DOI: 10.1097/01.mcg.0000174024.81096.44. View